Fierce Pharma
OCTOBER 30, 2024
Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to distributors. Baxter plans to exit China's IV fluids market as it faces tough local competition and as it redirects global IV supplies to the U.S. to cope with a post-hurricane shortage.
Fierce Pharma
OCTOBER 31, 2024
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | million euros over allegations that the company “[abused] its dominant market position to delay competition” to Copaxone across multiple EU member states.
World of DTC Marketing
JULY 21, 2021
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.
World of DTC Marketing
APRIL 20, 2022
We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. This was especially true with new drugs that have a significant competitive market. Will they transform their HCP marketing or stick to dated models?
Advertiser: ZoomInfo
Every go-to-market team knows the frustrations that come from a drawn-out sales process. Longer sales cycles. Larger buying committees. Slow-moving compliance reviews. How can you speed it up? By building a modern GTM motion that uses data, automation, and proven best practices to unlock insights, engage customers, and win faster.
MedCity News
SEPTEMBER 9, 2024
It explained that there is low competition among PBMs and high vertical integration with payers. The post AMA Report Details Low Competition in PBM Market appeared first on MedCity News. The American Medical Association released a new report on Monday on pharmacy benefit managers.
Fierce Pharma
JULY 11, 2023
The race for competitive advantage for pharma today is about far more than just innovative new molecules.
Advertiser: ZoomInfo
How should frontline sales professionals approach selling to the C-suite in today’s ultra-competitive market? We called on ZoomInfo’s top sales people — including our founder and CEO — to bring you the definitive guide for selling to the C-suite.
Advertiser: ZoomInfo
Intensifying competition. Go-to-market teams of every size, in every industry, are grappling with these challenges firsthand. Longer sales cycles. Increasingly discerning buyers. More meetings. Economic uncertainty. Thankfully, there’s an answer.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase.
Advertiser: ZoomInfo
That means placing the right people in the right roles can be the difference between your business growing or stagnating — and the competition is getting fierce. According to Harvard Business Review, the COVID-19 pandemic exacerbated seismic shifts that were already rocking the talent market.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks.
Advertisement
That's why Bigtincan teamed up with Heinz Marketing in a recent research study with the aim of discovering the roadblocks revenue-generating teams encounter in preparing buyer-facing teams for today’s market. Our research uncovered five key insights into what you can do today.
Expert insights. Personalized for you.
241 
Let's personalize your content